EP3045466
(2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVATE AS SGT2 INHIBITOR FOR THE TREATMENT OF DIABETES
:
EP einkaleyfi: Þýðing ekki lögð inn:
21.6.2007:
6.12.2017:
15181545.3
:
20.6.2027
:
(2S,3R,4S,5S,6R)-2-[4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL]-6-HYDROXYMETHYL-2-METHOXY-TETRAHYDRO-PYRAN-3,4,5-TRIOL PROPYLENE GLYCOL SOLVATE AS SGT2 INHIBITOR FOR THE TREATMENT OF DIABETES
21.6.2007
6.12.2017
:
AstraZeneca AB:
151 85 Södertälje, SE
:
GOUGOUTAS, Jack Z.:
Princeton, NJ New Jersey, US
:
NIRSCHL, Alexandra A.:
Yardley, PA Pennsylvania, US
:
SINGH, Janak:
Pennington, NJ New Jersey, US
:
DIMARCO, John D.:
Princeton, NJ New Jersey, US
:
LOBINGER, Hildegard:
Regensburg, DE
:
RAMAKRISHNAN, Srividya:
Miltown, NJ New Jersey, US
:
DESHPANDE, Prashant P.:
New Brunswick, NJ New Jersey, US
:
BIEN, Jeffrey T.:
New Brunswick, NJ New Jersey, US
:
LAI, Chiajen:
New Brunswick, NJ New Jersey, US
:
WANG, Chenchi:
New Brunswick, NJ New Jersey, US
:
RIEBEL, Peter:
Ruhstorf A.d.Rott, DE
:
GROSSO, John Anthony:
Princeton Junction, NJ New Jersey, US
:
817118 P:
28.6.2006:
US
:
765481:
20.6.2007:
US
:
C07H 7/04, C07H 15/207, A61K 31/7034, A61K 45/06, A61P 3/10